| Publication date | Communities | Collections | Article title | Author(s) | Journal/Conference |
|---|---|---|---|---|---|
| 18 Sep 2019 | BMRC | Bioinformatics Institute | Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization | Katie Paul Friedman, Matthew Gagne, Lit-Hsin Loo, Panagiotis Karamertzanis, Tatiana Netzeva, Tomasz Sobanski, Jill A. Franzosa, Ann M. Richard, Ryan R. Lougee, Andrea Gissi, Jia-Ying Joey Lee, Michelle Angrish, Jean Lou Dorne, Stiven Foster, Kathleen Raffaele, Tina Bahadori, Maureen R. Gwinn, Jason Lambert, Maurice Whelan, Mike Rasenberg, Tara Barton-Maclaren, Russell S. Thomas | Toxicological Sciences |